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ABSTRACT 
Objective: This research was to investigate the activity of Andrographis paniculata extract (APE) and Guazuma ulmifolia extract (GUE) in treating 
obesity integrated diabetic conditions.  
Methods: There were two stages of inductions: the first stage was a 42 d of high carbohydrate intake (obese with insulin resistance mice model), 
followed by second stage induction by giving of alloxan 50 mg/kg bw intravenously (obese diabetic mice model). Animals with glucose level>200 
mg/dl were then treated with metformin 195 mg/kg bw, glibenclamide 0.65 mg/kg bw, APE 2 g/kg bw, GUE 0.5 g/kg bw, combination of APE 1 
g/kg bw and GUE 0.25 g/kg bw, or combination of APE 2 g/kg bw and GUE 0.5 g/kg bw for 14 d.  
Results: The results showed that APE alone, GUE alone, and the combination of APE 2 g/kg bw and GUE 0.5 g/kg bw could improve insulin 
sensitivity in obese with insulin resistance mice model. Whereas the combination of APE 2 g/kg bw and GUE 0.5 g/kg bw could significantly decrease 
blood glucose level and body weight (p<0.05) in obese diabetic mice model compare to APE alone, GUE alone, or a combination of APE 1 g/kg bw and 
GUE 0.25 g/kg bw.  
Conclusion: It is concluded that APE 2 g/kg bw, GUE 0.5 g/kg bw, and combination of APE 2 g/kg bw and GUE 0.5 g/kg bw can improve insulin resistance 
conditions caused by obesity, while combination of APE 2 g/kg bw and GUE 0.5 g/kg bw has the best activity in treating obese diabetic conditions.  
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INTRODUCTION 
Diabetes mellitus is a metabolic disorder that affects the body’s 
ability to produce or use insulin. Insulin is a hormone produced in 
the pancreas that responsible for transport glucose (blood sugar) 
from the bloodstream into the cells so they can break it down and 
use it for immediate fuel. People cannot live without insulin [1]. 
Diabetes melitus is indicated by the blood glucose level elevation [2]. 
The frequency of type 2 diabetes mellitus is 90% of cases globally [3]. 
Type 2 diabetes mellitus is a metabolism disorder with multifactorial 
cause, including lack of insulin secretion and peripheral insulin 
resistance. Pancreatic β cell dis-function is a major cause of this disorder, 
but the factor that trigger this β cell dis-function is still unclear [4].  
Obesity is the main cause in type 2 diabetes mellitus case. About 80% 
of type 2 diabetes patients are overweight [3, 5]. Normal glucose 
regulation is controlled by balance act between pancreatic β cell 
insulin secretion and insulin sensitivity in peripheral tissue (muscle, 
liver, and adipose tissue). Insulin resistance is a major symptom in a 
metabolic syndrome and frequently develop into type 2 diabetes 
mellitus. Decreasing insulin sensitivity and damaged pancreatic β cell 
are the major pathogenesis in the type 2 diabetes mellitus [6].  
Clinically, obesity is defined as a condition where individual’s body mass 
index is more than or equal to 30 kg/m². Obesity is able to affect an 
individual in any age, but the exact etiology of this disease is still unclear. 
But it is already known that obesity is a result from chronic imbalance 
between energy intake and energy spending [5]. Obesity and insulin 
resistance usually initiate impaired glucose condition. So the link 
between obesity and type 2 diabetes mellitus is insulin resistance, which 
is marked by lower decreasing in glucose level upon glucose 
administration. It is known that severity and duration of obesity is the 
main risk factor in type 2 diabetes mellitus. In simple term, elevated 
body weight can cause hyperinsulinemia and insulin resistance [5].  
Andrographis paniculata (Burm. F.) Wallich. ex. Nees., belongs to 
Acanthaceae family [7], known in Indonesia as sambiloto, traditionally 
has been used as a hypoglycemic agents [8]. Previous research shows 
that Andrographis paniculata has the ability to lower blood glucose 
level in diabetic animal [9-11]. Major chemical compounds in A. 
paniculata are diterpenoid, flavonoid, and poliphenol. Main chemical 
constituent and active compound is andrographolide, belongs to 
diterpenoid group, a crystalline compound with bitter taste, mostly 
contain in leaves (>2%) [12, 13]. A. paniculata’s mechanism in 
decreasing blood glucose level is by increasing insulin secretion from 
undamaged pacreatic β cell, improving insulin sensitivity, and slowing 
down the insulin resistance development [14, 15].  
Guazuma ulmifolia Lamk., belongs to Sterculiaceae family [16], known 
in Indonesia as jati belanda, traditionally has been used as a body 
weight reducing agents. A chemical constituent in G. ulmifolia is an 
alkaloid, flavonoid, saponin group, and tannin as main constituent [8]. 
Tiliroside is the marker compound in G. ulmifolia [17]. The previous 
study showed that G. ulmifolia had the ability to inhibit cholesterol and 
LDL level elevation [18]. Moreover, G. ulmifolia shows antidiabetic 
activity; the mechanism was thought to increase insulin secretion [19]. 
The epidemiology study suggested that increasing prevalent of 
diabetic was parallel to obesity. Body mass index and waist 
circumference played an important role in type 2 diabetes mellitus 
development [6]. So one of the aim of this study was to develop an 
obese diabetic mice model. Based on the previous study and 
traditional use, a combination of these two plants was thought to be 
effective in treating the obese diabetic condition. The combination 
on these two plant extracts in treating obese diabetic condition in 
mice has never been investigated before.  
MATERIALS AND METHODS 
Identification and authentication of plant material  
Identified Andrographis paniculata (Burm. f.) Wallich. ex Nees. and 
Guazuma ulmifolia Lamk. plants were obtained from Bumi Herbal, 
Bandung, West Java, Indonesia. Fresh plants were dried at 60-70 °C 
and then grinded into small pieces.  
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Preparation of ethanolic extract of Andrographis paniculata  
1 kg dried herbs of Andrographis paniculata was macerated with 10 L 
ethanol, twice. The mixture was filtered using a filter paper, and the 
filtrate was concentrated using rotary vacuum evaporator at 60 °C [14]. 
Preparation of water extract of Guazuma ulmifolia  
1 kg dried leaves of Guazuma ulmifolia was mixed with 15 L water 
and boiled for 30 min. The mixture was filtered and dried using 
freeze dryer [18].  
Animals 
Male Swiss–Webster mice 2-3 m old weighing 20-35 g from 
Pharmacology Laboratory, Bandung Institute of  Technology. The 
animals were kept at standard laboratory conditions at 24-26 °C, 
humidity 70-75%, and 12 h light/dark cycle. Animals were fed with 
standard chow and water ad libitum. The methods in this study were 
performed in accordance with ethics and guide for animals care and 
used. 
Oral glucose tolerance test 
Before the commencement of the experiment and after first stage 
induction using high carbohydrate diet, an oral glucose tolerance 
test (OGTT) using glucose 3 g/kg bw was performed after a 12-hour 
fasting period. Blood glucose concentration from the tail vein was 
measured using the Easy Touch® blood glucose meter at 0 and 30, 
60, 90 and 120 min after glucose administration [14]. 
Insulin tolerance test  
After first stage induction using high carbohydrate diet, an insulin 
tolerance test (ITT) using insulin 0.75 U/kg bw, ip, was performed. 
Blood glucose concentration from the tail vein was measured using the 
Easy Touch® blood glucose meter at 0, 15, 30, 45, and 60 min [20]. 
Induction of obese diabetic mice  
There were two stages of induction. The objective of the first stage 
was to develop obese with insulin resistance mice model. Forty two 
days of high carbohydrate diet intake [21] was performed, then 
insulin tolerance test was done. Then to develop obese diabetic mice, 
the second stage induction was performed by administering aloxan 
50 mg/kg bw intravenously [22]. 
Antidiabetic assessment of extracts on induced animals  
After aloxan administration and hyperglycemic condition developed 
(blood glucose>200 mg/dl), animals divided into 7 groups (positive 
control, metformin 195 mg/kg bw, glibenclamide 0.65 mg/kg bw, 
APE 2 g/kg bw, GUE 0.5 g/kg bw, combination of APE 1 g/kg bw and 
GUE 0.25 g/kg bw, combination of APE 2 g/kg bw and GUE 0.5 g/kg 
bw) and 1 negative control group. The dose was selected based on 
previous researches or based on traditional use. [8, 14, 23, 24]. All 
groups were being treated with standard drugs or extracts for 14 d. 
Body weight and blood glucose level were measured as a parameter 
during the experiment. 
RESULTS AND DISCUSSION 
Effect of single and combination extracts in reducing blood 
glucose upon glucose administration 
Oral glucose tolerance test was performed to the healthy animal as a 
preliminary study. Blood glucose level profile was shown in fig. 1. 
Thirty minutes after glucose administration, blood glucose level in 
all groups increased as a response to oral glucose administration. 
Blood glucose increasing at minutes 30 in the control group was 
significantly higher among the other groups. 
At minutes 30 after glucose administration, a combination of 
Andrographis paniculata extract 2 g/kg bw and Guazuma ulmifolia 
extract 0.5 g/kg bw showed the lowest blood glucose level. From 
this study, it is known that both Andrographis paniculata extract and 
Guazuma ulmifolia extract, in single or combination administration, 
have the ability to suppress the increase of blood glucose upon 
glucose administration. 
Increase of body weight can reduce insulin sensitivity 
Body weight increasing profile during high carbohydrate diet was 
shown in fig. 2. 
  
 
Fig. 1: Blood glucose level profile in oral glucose tolerance test  
Note: APE = Andrographis paniculata extract, GUE = Guazuma ulmifolia extract. p<0.05, n≥4 mice/group 
 
 
Fig. 2: Body weight profile during high carbohydrate diet intake  
Note: p<0.05, n≥4 mice/group 
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After 42 d administration of high carbohydrate diet, body weight 
increasing percentage in the treatment group was significantly 
higher (p<0.05) compared to the control group. It suggests that high 
carbohydrate diet intake can induce obesity in mice compared to 
control group. This result collaborated with a previous study that 
done by Setiawan F, et al. [21]. 
Insulin tolerance test was performed after 42 d of high carbohydrate 
diet induction. Insulin sensitivity was stated with KITT. Lower KITT 
indicates lower insulin sensitivity. 
According to table 1, the high carbo diet group had lower KITT value 
compared to the control group, although it was statistically 
unsignificant (p=0.183). However, it suggested that body weight 
elevation could cause insulin sensitivity decreasing. This data is 
collaborate with a study done by Ble-Castillo et. al. that showed a 
high carbohydrate diet induce a higher insulin resistance and 
hepatic cholesterol content compared to a high-fat diet [25]. 
Effect of single and combination extracts in reducing blood 
glucose upon glucose administration in obese mice model 
Oral glucose tolerance test was performed to obese with insulin 
resistance mice model in order to compare the blood glucose 
lowering activity between single and combination extracts. Blood 
glucose level profile showed in fig. 3. 
 
Table 1: KITT value 
Group KITT 
High carbo diet 0.316±0.785 
Control diet 0.565±0.478 
Note: Data are presented as mean±SD, p<0.05, n= ≥ 4 mice/group.  
 
 
Fig. 3: Blood glucose percentage profile in oral glucose tolerance test to obese mice  
Note: APE = Andrographis paniculata extract, GUE = Guazuma ulmifolia extract. p<0.05, n≥4 mice/group 
 
On this study, oral glucose tolerance test was performed to obese 
mice model with insulin resistance. The aim of this test was to 
investigate the activity of both single and combination extracts in 
improving insulin sensitivity. Metformin, one of oral antidiabetic 
drugs and belongs to biguanide group, is used as standard drugs. It has 
the ability to increase insulin sensitivity in hepatic and peripheral 
tissue (muscle), that improve glucose uptake to insulin-sensitive 
tissue. Detail mechanism of how biguanide group increase sensulin 
sensitivity is still under observation, though it is thought that 
activation of adenosine-5-monophosphate, increasing tyrosin kinase 
activity, and activation of glucose transporter-4 take an important 
place. Metformin do not have any activity to pancreatic β cell [26].  
At minutes 30 after glucose administration, metformin as a standard 
drug group attenuated the increase of blood glucose level 
significantly compared to positive control group. The similar result 
was observed in Andrographis paniculata extract 2 g/kg bw and the 
combination of Andrographis paniculata extract 2 g/kg bw and 
Guazuma ulmifolia extract 0.5 g/kg bw. This suggests that 
Andrographis paniculata extract 2 g/kg bw and the combination of 
Andrographis paniculata extract 2 g/kg bw and Guazuma ulmifolia 
extract 0.5 g/kg bw can improve insulin sensitivity in obese with 
insulin resistance mice model. 
Effect of single and combination extracts in obese diabetic mice 
model 
Developed obese diabetic mice model was divided into 7 groups 
(positive control, metformin 195 mg/kg bw, glibenclamide 0.65 
mg/kg bw, APE 2 g/kg bw, GUE 0.5 g/kg bw, combination of APE 1 
g/kg bw and GUE 0.25 g/kg bw, and combination of APE 2 g/kg bw 
and GUE 0.5 g/kg bw) and negative control group. Standard drugs 
and extracts were given for 14 d. The pparameters’ were blood 
glucose level and body weight measurement. Blood glucose level 
profile during the treatment period was shown on table 2. 
 
Table 2: Blood glucose level percentage profile 
Group Percentage of blood glucose level increasing profile (d) 
3 7 10 14 
Negative control 100.30±7.64 124.89±32.15 114.31±31.82 93.53±19.79 
Positive control 95.49±13.34 106.57±34.88 118.09±38.00 117.13±25.22 
Metformin 195 mg/kg bw 89.65±21.15 98.01±42.00 114.44±21.33 106.21±48.29 
Glibenclamide 0.65 mg/kg bw 108.32±32.86 106.38±18.40 114.41±32.82 88.33±17.00 
APE 2 g/kg bw  81.65±27.31 85.26±35.65 97.06±33.46 82.15±22.92 
GUE 0.5 g/kg bw 92.35±15.78 124.67±22.48 132.05±32.75 117.80±36.27 
APE 2 g/kg bw & GUE 0.5 g/kg bw 71.02±13.03 81.21±36.50 83.80±37.69 66.01±40.91* 
APE 1 g/kg bw & GUE 0.25 g/kg bw 78.50±11.39 89.61±24.09 99.86±13.12 98.50±51.13 
Note: Data are presented as mean±SD, n ≥ 4 mice/group, * means significantly different compared to positive control, p<0.05 
Aligita et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 1, 316-320 
319 
According to table 2, glibenclamide, Andrographis paniculata extract 2 
g/kg bw, combination of Andrographis paniculata extract 2 g/kg bw and 
Guazuma ulmifolia extract 0.5 g/kg bw, and combination of Andrographis 
paniculata extract 1 g/kg bb and Guazuma ulmifolia extract 0.25 g/kg bw 
group showed blood glucose decreasing after 14 d of treatment. But 
significant blood glucose level decreasing percentage (p<0.05) was 
shown only by a combination of Andrographis paniculata extract 2 g/kg 
bw and Guazuma ulmifolia extract 0.5 g/kg bw group.  
Body weight, another parameter in this study, was also measured. 
According to table 3, all groups had body weight decreasing 
compared to before treatment’s value. After 14 d treatment, 
glibenclamide and combination of Andrographis paniculata extract 2 
g/kg bw and Guazuma ulmifolia extract 0.5 g/kg bw group showed 
significant decrease in animal’s body weight (p<0.05) compared to 
control group. 
The result showed that after 14 d treatment, combination of 
Andrographis paniculata extract 2 g/kg bw and Guazuma ulmifolia 
extract 0.5 g/kg bw could significantly decrease both blood glucose 
level and body weight compared to positive control group. The 
result from this study showed comparable data with the hypothesis. 
 
Table 3: Body weight percentage profile 
Group Percentage of body weight profile (d) 
3 7 10 14 
Negative control 91.54±2.14 97.06±3.20 92.64±1.53 92.93±0.78 
Positive control 87.59±2.60 85.59±3.79 85.00±4.19 85.47±4.67 
Metformin 195 mg/kg bw 85.92±3.39 84.81±2.50 84.35±3.60 81.88±4.70 
Glibenclamide 0.65 mg/kg bw 88.42±2.68 91.49±15.86 82.86±2.87 79.20±4.11* 
APE 2 g/kg bb  86.82±3.19 85.08±3.26 84.29±2.85 85.71±3.08 
GUE 0.5 g/kg bb 87.54±0.96 86.59±2.07 85.51±2.58 85.38±3.85 
APE 2 g/kg bb & GUE 0.5 g/kg bb 85.73±2.94 82.32±3.59 79.79±3.41 78.94±2.91* 
APE 1 g/kg bb & GUE 0.25 g/kg bb 87.95±1.31 82.69±5.60 81.42±4.48 81.61±4.75 
Note: Data are presented as mean±SD, n≥4 mice/group, * means significantly different compared to positive control, p<0.05 
 
Andrographis paniculata’s mechanism in decreasing blood glucose 
level is by increasing insulin secretion from undamaged pancreatic β 
cell, improving insulin sensitivity, and slowing down the insulin 
resistance development [13, 14]. The mechanism of Guazuma 
ulmifolia in reducing body weight is still unclear. In this study, a 
combination of Andrographis paniculata 2 g/kg bw and Guazuma 
ulmifolia extract 0.5 g/kg bw showed the best activity in reducing 
blood glucose and body weight of obese diabetic mice model (table 3 
& 4). This result suggests that one of the probable mechanism of this 
extract combination is by improving insulin sensitivity and 
decreasing body weight.  
CONCLUSION 
From this study, it is concluded that Andrographis paniculata extract 
2 g/kg bw, GUE 0.5 g/kg bw, and combination of Andrographis 
paniculata extract 2 g/kg bw and Guazuma ulmifolia extract 0.5 g/kg 
bw can improve insulin resistance conditions caused by obesity 
while combination of Andrographis paniculata extract 2 g/kg bw and 
Guazuma ulmifolia extract 0.5 g/kg bw give the best antidiabetic 
activity to treat obese diabetic conditions.  
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